Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$20.88 - $35.19 $2,296 - $3,870
-110 Reduced 12.09%
800 $24,000
Q1 2022

May 11, 2022

BUY
$29.0 - $47.27 $2,871 - $4,679
99 Added 12.21%
910 $29,000
Q4 2021

Jan 10, 2022

BUY
$42.59 - $55.02 $19,208 - $24,814
451 Added 125.28%
811 $36,000
Q3 2021

Nov 24, 2021

SELL
$48.48 - $78.23 $1,890 - $3,050
-39 Reduced 9.77%
360 $18,000
Q2 2021

Jul 30, 2021

BUY
$50.3 - $78.44 $2,464 - $3,843
49 Added 14.0%
399 $31,000
Q4 2020

Jan 15, 2021

SELL
$36.89 - $93.56 $5,533 - $14,034
-150 Reduced 30.0%
350 $29,000
Q3 2020

Oct 21, 2020

SELL
$23.13 - $38.84 $69,390 - $116,520
-3,000 Reduced 85.71%
500 $18,000
Q2 2020

Jul 10, 2020

SELL
$16.01 - $28.82 $24,015 - $43,230
-1,500 Reduced 30.0%
3,500 $85,000
Q1 2020

Apr 15, 2020

BUY
$14.2 - $27.98 $1,420 - $2,798
100 Added 2.04%
5,000 $88,000
Q4 2019

Jan 22, 2020

BUY
$14.4 - $19.99 $56,160 - $77,961
3,900 Added 390.0%
4,900 $85,000
Q1 2019

Apr 29, 2019

SELL
$17.99 - $24.65 $764,898 - $1.05 Million
-42,518 Reduced 97.7%
1,000 $21,000
Q4 2018

Feb 04, 2019

SELL
$13.88 - $21.75 $32,201 - $50,460
-2,320 Reduced 5.06%
43,518 $899,000
Q3 2018

Oct 30, 2018

SELL
$12.46 - $21.74 $105,498 - $184,072
-8,467 Reduced 15.59%
45,838 $967,000
Q2 2018

Aug 14, 2018

BUY
$15.25 - $21.02 $71,110 - $98,016
4,663 Added 9.39%
54,305 $828,000
Q1 2018

May 14, 2018

BUY
$15.36 - $24.8 $762,501 - $1.23 Million
49,642 New
49,642 $931,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.88B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.